Breaking News
DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
Cannabis Buyers Are Price-Sensitive, Now The Federal Data Proves It
LOS ANGELES – The study, published this month in the ...
Argent BioPharma Licenses Proprietary Cannabis Genetics in Global Thai Phytomed Agreement
LONDON / PERTH – Argent BioPharma Ltd. has signed a ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
New York Cannabis Tops $4 Billion in Retail Sales
NEW YORK – Less than four years after the state welcomed its first licensed adult-use customer, New York's regulated market has crossed a major cumulative sales threshold, placing it among the top three recreational Cannabis ...
SNDL Reports Q3 2026 Financial and Operational Results
EDMONTON – SNDL Inc. released its third-quarter 2026 results, reporting record quarterly free cash flow of CA$20.0 million, up 19.5% YoY, and a return to positive adjusted operating income of $5.2 million, compared with a ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The Cannabis and Psychedelics industries closed out the past fortnight with a full plate of international boardrooms debates, M&A combat, a federal rescheduling docket moving toward a recommended decision, ballot momentum heading ...
